Literature DB >> 18559950

The essential role of the in situ immune reaction in human colorectal cancer.

Franck Pagès1, Jérôme Galon, Wolf H Fridman.   

Abstract

Colorectal cancer is the second most common cause of cancer-related death. Novel prognostic factors should be identified and validated to refine the present tumor-node-metastasis system. The presence of immune cells infiltrating colorectal cancers is a common phenomenon. However, the current belief is that clinically detectable human tumors escaping immune surveillance are no longer kept in check by the immune cells of the tumor microenvironment. Despite studies showing the influence of immune cell infiltrates on the behavior of colorectal carcinomas, this parameter is not currently recognized as a reliable prognostic factor. We showed that the nature, functional orientation, density, and location of immune cells within distinct tumor regions could provide a prognostic factor superior to and independent of criteria related to the anatomic extent of the tumor. The strength of the immune reaction identified in our studies could advance our understanding of cancer evolution and have important consequences for clinical practice.

Entities:  

Mesh:

Year:  2008        PMID: 18559950     DOI: 10.1189/jlb.1107773

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  58 in total

1.  Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.

Authors:  Yunmei Liao; Juanjuan Ou; Jia Deng; Peiliang Geng; Rui Zeng; Yi Tian; Houjie Liang; Bing Ni; Zhihua Ruan
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

Review 2.  Microbiota and immune responses in colon cancer: more to learn.

Authors:  Florencia McAllister; Franck Housseau; Cynthia L Sears
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 3.  Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Authors:  Adam J Bograd; Kei Suzuki; Eva Vertes; Christos Colovos; Eduardo A Morales; Michel Sadelain; Prasad S Adusumilli
Journal:  Cancer Immunol Immunother       Date:  2011-09-13       Impact factor: 6.968

4.  Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study.

Authors:  Anna E Prizment; Kristin E Anderson; Kala Visvanathan; Aaron R Folsom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

5.  Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.

Authors:  Vanessa Deschoolmeester; Marc Baay; Filip Lardon; Patrick Pauwels; Marc Peeters
Journal:  Cancer Microenviron       Date:  2011-05-27

6.  A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.

Authors:  Jeremy B Foote; Marleen Kok; James M Leatherman; Todd D Armstrong; Bridget C Marcinkowski; Laureen S Ojalvo; David B Kanne; Elizabeth M Jaffee; Thomas W Dubensky; Leisha A Emens
Journal:  Cancer Immunol Res       Date:  2017-05-08       Impact factor: 11.151

Review 7.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

8.  Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Authors:  Anna M Sherwood; Ryan O Emerson; Dominique Scherer; Nina Habermann; Katharina Buck; Jürgen Staffa; Cindy Desmarais; Niels Halama; Dirk Jaeger; Peter Schirmacher; Esther Herpel; Matthias Kloor; Alexis Ulrich; Martin Schneider; Cornelia M Ulrich; Harlan Robins
Journal:  Cancer Immunol Immunother       Date:  2013-06-16       Impact factor: 6.968

9.  Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.

Authors:  Laura T Pelegrina; María Gabriela Lombardi; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; María E Sales
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

10.  Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.

Authors:  Shuji Ogino; Katsuhiko Nosho; Natsumi Irahara; Jeffrey A Meyerhardt; Yoshifumi Baba; Kaori Shima; Jonathan N Glickman; Cristina R Ferrone; Mari Mino-Kenudson; Noriko Tanaka; Glenn Dranoff; Edward L Giovannucci; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.